Zentalis (ZNTL) announced the appointment of James Bucher as chief legal officer and corporate secretary, effective September 18. Andrea Paul, who has served as Zentalis’ chief legal officer and Corporate Secretary since 2022, will be departing the company to join the partnership of a law firm. Most recently, Bucher served as chief legal officer at Harpoon Therapeutics.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZNTL:
- Zentalis price target lowered to $5 from $6 at Wells Fargo
- Strategic Advancements and Promising Clinical Data Support Buy Rating for Zentalis Pharmaceuticals
- Zentalis Pharmaceuticals: Hold Rating Amid Delayed Catalysts and Market Skepticism
- Zentalis Pharmaceuticals Reports Improved Financial Results
- Zentalis Pharmaceuticals Reports Q2 2025 Financial Results